The impact and cost of the 2013 WHO recommendations on eligibility for antiretroviral therapy

AIDS

Volumn 28, Issue SUPPL. 2, 2014, Pages

  Stover, John ^a   Gopalappa, Chaitra ^a   Mahy, Mary ^b   Doherty, Meg C ^c   Easterbrook, Philippa J ^c   Weiler, Gundo ^c   Ghys, Peter D ^b  

^a AVENIR HEALTH   (United States)

^b UNAIDS ^*  (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

antiretroviral therapy; cost; guidelines; impact

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; TENOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; DRUG COST; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; INCIDENCE; LOWEST INCOME GROUP; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCALE UP; WORLD HEALTH ORGANIZATION; ADULT; DEVELOPING COUNTRY; ECONOMICS; FEMALE; HEALTH; HIV INFECTIONS; INFANT; MALE; PREGNANCY; PRESCHOOL CHILD; THEORETICAL MODEL;

ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; FEMALE; GLOBAL HEALTH; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; MALE; MODELS, THEORETICAL; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; WORLD HEALTH ORGANIZATION;

EID: 84901435690     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000235     Document Type: Article

References (15)

1. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2013, www.who.int/hiv/pub/guidelines/arv2013. [Accessed 26 January 2014]
2. Hirnschall G, Harries AD, Easterbrook PJ, Doherty MC, Ball A. The next generation of the World Health Organization's global antiretroviral guidance. J Int AIDS Soc 2013; 16:18757; doi: 10.7448/IAS.16.1.18757.
3. UNAIDS. Global Report: UNAIDS report on the global AIDS epidemic 2013. Geneva: United Nations Joint Programme on HIV/AIDS; 2013.
4. Stover J, Brown T, Marston M. Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children (2012). Sex Trans Infect 2012; 88:i11-ii16; doi: 10.1136/sextrans-2012-050640.
5. Yiannoutsos CT, Johnson LF, Boulle A, Musick BS, Gsponer T, Balestre E, et al. Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy. Sex Trans Infect 2012; 88:i33-i43; doi:10.1136/sextrans-2012-050658.
6. Rollins N, Mahy M, Becquet R, Kuhn L, Creek T, Mofenson L. Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models. Sex Trans Infect 2012; 88:i44-i51; doi:10.1136/srxtrans-2012-050709.
7. Futures Institute. Goals manual: a model for estimating the effects of interventions and resource allocation on HIV infections and deaths, August 2011. www.FuturesInstitute.org. [Accessed January 10, 2014].
8. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
9. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010; 375:2092-2098.
10. Tanser F, Barnighausen T, Graspa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural Kwa-Zulu Natal. South Afr Sci 2013; 339:966; doi:10.1126/science.1228160.
11. He N, Duan S, Ding Y, Rou K, McGoogan J, Jia M, et al. Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, China. PLoS One 2013; 8:e77981; doi: 10.1371/journal.pone.0077981.
12. World Health Organization. Antiretroviral drugs for HIV infection in adults and adolescents: recommendations for a public health approach [2006 revision]. Geneva: World health Organization, 2006, http://www.who.int/hiv/pub/ guidelines/artadultguidelines.pdf. [Accessed 26 January 2014]
13. Menzies NA, Berruti AA, Blandford JM. The determinants of HIV treatment costs in resource limited settings. PLoS One 2012; 7:e48726doi: 10.1371/journal.pone.0048726.
14. Commission on Macroeconomics and Health. Macroeconomics and health: investing in health for economic development. Boston: Center for International Development at Harvard University; 2001.
15. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 5859:2197-2223; doi:10.1016/S0140-6736(12)61689-4.